Literature DB >> 23164564

Burden of pneumococcal infection in adults in Colombia.

Diego Rosselli1, Juan-David Rueda.   

Abstract

INTRODUCTION: The burden of Streptococcus pneumoniae infections is highest in children. Estimates in adult population are uncommon. We determined the burden of disease associated with pneumococcus in adults in Colombia in year 2008.
METHODOLOGY: Using different data sources (official mortality records, medical databases, published literature and local epidemiological data) we estimated prevalence, incidence, mortality and disability due to bacterial pneumonia, bacterial meningitis and bacteremia of any cause for year 2008, and the fraction of these that can be attributed to S. pneumoniae.
RESULTS: A total of 63,463 DALYs are lost due to S. pneumoniae in Colombians age 15 or over. Most of this burden (51,848 DALYs, 81.7%) is due to pneumonia, followed by meningitis (9241 DALYs, 14.6%). The three conditions, overall, represent 2.03 DALYs per 1000 Colombians in that age range.
CONCLUSIONS: Despite the lower incidence of pneumococcal disease in adults, as compared with children, its burden is still significant, comparable to that of schizophrenia or epilepsy. This study may provide a benchmark for future preventive interventions.
Copyright © 2012 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23164564     DOI: 10.1016/j.jiph.2012.04.003

Source DB:  PubMed          Journal:  J Infect Public Health        ISSN: 1876-0341            Impact factor:   3.718


  7 in total

1.  Invasive Pneumococcal Disease Characterization in Adults and Subgroups aged < 60 years and ≥ 60 years in Bogota, Colombia.

Authors:  Aura Lucia Leal Castro; Germán Camacho-Moreno; Anita Montañez-Ayala; Fabio Varón-Vega; José Camilo Alvarez-Rodríguez; Sandra Valderrama-Beltrán; Beatriz Elena Ariza; Oscar Pancha; Ana Yadira Santana; Nella Sánchez Flórez; Patricia Reyes; Jaime Ruiz; Claudia Beltran; Emilia Prieto; Monica Rojas; Juan Urrego-Reyes; Cintia Irene Parellada
Journal:  IJID Reg       Date:  2022-04-28

2.  Attributable healthcare utilization and cost of pneumonia due to drug-resistant streptococcus pneumonia: a cost analysis.

Authors:  Courtney A Reynolds; Jonathan A Finkelstein; G Thomas Ray; Matthew R Moore; Susan S Huang
Journal:  Antimicrob Resist Infect Control       Date:  2014-05-21       Impact factor: 4.887

3.  Local attributable burden disease to PM 2.5 ambient air pollution in Medellín, Colombia, 2010-2016.

Authors:  Hugo Grisales-Romero; Juan Gabriel Piñeros-Jiménez; Emmanuel Nieto; Sandra Porras-Cataño; Nora Montealegre; Difariney González; Dorian Ospina
Journal:  F1000Res       Date:  2021-05-28

4.  Blocking neurogenic inflammation for the treatment of acute disorders of the central nervous system.

Authors:  Kate Marie Lewis; Renée Jade Turner; Robert Vink
Journal:  Int J Inflam       Date:  2013-05-29

5.  Availability of secondary healthcare data for conducting pharmacoepidemiology studies in Colombia: A systematic review.

Authors:  Juan-Sebastian Franco; David Vizcaya
Journal:  Pharmacol Res Perspect       Date:  2020-10

6.  Trends in all-cause pneumonia and otitis media in children aged <2 years following pneumococcal conjugate vaccine introduction in Colombia.

Authors:  Gabriel Carrasquilla; Alexandra Porras-Ramírez; Sandra Martinez; Rodrigo DeAntonio; Raghavendra Devadiga; Carla Talarico; Diana C Caceres; Maria M Castrejon; Patricia Juliao
Journal:  Hum Vaccin Immunother       Date:  2020-09-23       Impact factor: 3.452

7.  Bacteremic pneumococcal pneumonia: serotype distribution, antimicrobial susceptibility, severity scores, risk factors, and mortality in a single center in Chile.

Authors:  Alberto Fica; Nicolás Bunster; Felipe Aliaga; Felipe Olivares; Lorena Porte; Stephanie Braun; Jeannette Dabanch; Juan Carlos Hormázabal; Antonio Hernández; María Guacolda Benavides
Journal:  Braz J Infect Dis       Date:  2013-10-10       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.